NORGES BANK - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 155 filers reported holding CONMED CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CONMED CORP
ValueSharesWeighting
Q4 2022$15,963,975
+1.5%
180,099
-8.2%
0.00%0.0%
Q3 2022$15,725,666
-9.1%
196,154
+8.6%
0.00%0.0%
Q2 2022$17,297,895
-44.0%
180,638
-13.2%
0.00%
-42.9%
Q1 2022$30,909,690
+15.8%
208,076
+10.5%
0.01%
+40.0%
Q4 2021$26,698,000
+11.8%
188,331
+3.2%
0.01%0.0%
Q3 2021$23,884,000
-22.2%
182,556
-18.3%
0.01%
-28.6%
Q2 2021$30,702,000
-7.1%
223,403
-11.7%
0.01%
-12.5%
Q1 2021$33,039,000
+8.8%
252,997
-6.7%
0.01%
+14.3%
Q4 2020$30,368,000
+44.7%
271,143
+1.6%
0.01%
+16.7%
Q3 2020$20,989,000
-26.2%
266,797
-32.4%
0.01%
-25.0%
Q2 2020$28,429,000
+12.2%
394,904
-10.8%
0.01%
-11.1%
Q1 2020$25,341,000
-51.3%
442,487
-4.9%
0.01%
-40.0%
Q4 2019$52,020,000
+7.4%
465,174
-7.7%
0.02%0.0%
Q3 2019$48,447,000
+12.4%
503,8620.0%0.02%
+15.4%
Q2 2019$43,115,000
+0.4%
503,862
-2.4%
0.01%
-7.1%
Q1 2019$42,942,000
+29.6%
516,2610.0%0.01%
+16.7%
Q4 2018$33,144,000
-19.0%
516,2610.0%0.01%
-7.7%
Q3 2018$40,898,000
+8.2%
516,2610.0%0.01%0.0%
Q2 2018$37,791,000
+36.1%
516,261
+17.8%
0.01%
+30.0%
Q1 2018$27,762,000
+47.6%
438,361
+18.8%
0.01%
+42.9%
Q4 2017$18,807,000
-15.6%
368,985
-13.2%
0.01%
-12.5%
Q3 2017$22,293,000
+25.5%
424,871
+21.8%
0.01%
+14.3%
Q2 2017$17,763,000
+51.8%
348,714
+32.3%
0.01%
+40.0%
Q1 2017$11,702,000
+26.7%
263,510
+26.0%
0.01%
+25.0%
Q4 2016$9,236,000
+83.9%
209,101
+59.4%
0.00%
+100.0%
Q3 2016$5,021,000
-64.0%
131,219
-55.1%
0.00%
-71.4%
Q2 2016$13,953,000
+13.8%
292,3330.0%0.01%
+16.7%
Q1 2016$12,260,000
-4.8%
292,3330.0%0.01%0.0%
Q4 2015$12,877,000
-7.7%
292,3330.0%0.01%
-14.3%
Q3 2015$13,956,000
-18.1%
292,3330.0%0.01%
-22.2%
Q2 2015$17,034,000
+15.4%
292,3330.0%0.01%
+28.6%
Q1 2015$14,760,000
+12.3%
292,3330.0%0.01%0.0%
Q4 2014$13,143,000
+22.0%
292,3330.0%0.01%
+16.7%
Q3 2014$10,769,000
-45.4%
292,333
-34.6%
0.01%
+20.0%
Q2 2014$19,730,000
+103.2%
446,856
+100.0%
0.01%0.0%
Q1 2014$9,708,000
+2.2%
223,4280.0%0.01%0.0%
Q4 2013$9,496,000
+25.0%
223,4280.0%0.01%
+25.0%
Q3 2013$7,594,000
+22.2%
223,428
+12.3%
0.00%0.0%
Q2 2013$6,216,000
+89.3%
198,955
+106.4%
0.00%
+100.0%
Q1 2013$3,283,000
+19.5%
96,3730.0%0.00%0.0%
Q3 2012$2,747,000
+3.9%
96,3730.0%0.00%0.0%
Q2 2012$2,644,00096,3730.00%
Other shareholders
CONMED CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders